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O R I G I N A L  A R T I C L E
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1Department of Epidemiology, Fielding School of Public Health, and  2David Geffen School of Medicine, University of California, Los Angeles; 3School of Medicine, Kinshasa 
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Background. Transient immunosuppression and increased susceptibility to other infections after measles infection is well 
known, but recent studies have suggested the occurrence of an “immune amnesia” that could have long-term immunosuppressive 
effects.
Methods. We examined the association between past measles infection and acute episodes of fever, cough, and diarrhea among 
2350 children aged 9 to 59 months whose mothers were selected for interview in the 2013–2014 Democratic Republic of the Congo 
(DRC) Demographic and Health Survey (DHS). Classification of children who had had measles was completed using maternal recall 
and measles immunoglobulin G serostatus obtained via dried-blood-spot analysis with a multiplex immunoassay. The association 
with time since measles infection and fever, cough, and diarrhea outcomes was also examined.
Results. The odds of fever in the previous 2 weeks were 1.80 (95% confidence interval [CI], 1.25–2.60) among children for 
whom measles was reported compared to children with no history of measles. Measles vaccination demonstrated a protective asso-
ciation against selected clinical markers of acute infectious diseases.
Conclusion. Our results suggest that measles might have a long-term effect on selected clinical markers of acute infectious dis-
eases among children aged 9 to 59 months in the DRC. These findings support the immune-amnesia hypothesis suggested by others 
and underscore the need for continued evaluation and improvement of the DRC’s measles vaccination program.
Keywords. cough, diarrhea, fever, immunosuppression, measles.
 
Measles is primarily a highly transmissible childhood viral di-
sease caused by a single-stranded RNA paramyxovirus (genus 
Morbillivirus). Vaccination with currently used measles vac-
cines results in long-lasting immunity; seroconversion rates are 
85% when children are vaccinated at 9 months of age and ap-
proximately 95% after 1 dose of vaccine among children aged 
12 months or older [1, 2]. World Health Organization guidance 
recommends that all countries include a second routine dose 
of measles vaccine, even in countries with low national cov-
erage of the first dose [3]. Countries in which measles is en-
demic, such as the Democratic Republic of the Congo (DRC), 
should routinely vaccinate children at 9 months and then at 12 
to 15 months of age to protect those who might not have de-
veloped immunity after their first dose [4]. In 2015, the DRC 
reported 79% national coverage for the first dose of measles vac-
cination [3], and measles ranked 15th among the top causes of 
death in children less than 5 years of age in the DRC in 2016 [5].
In addition to its high burden in DRC children, measles has 
more severe effects on child health as a result of widespread im-
munosuppression that stems from malnutrition. The DRC’s 2013–
2014 Demographic and Health Survey (DHS) found that 23% of 
children younger than 5 years were acutely malnourished (wasted), 
and 43% were chronically malnourished (stunted) [6]. Malnutrition 
has been linked to dysfunction of cell-mediated immunity [7] and, 
in poor regions, increased risk of morbidity and death in those 
with measles. In 1998, Belamarich [8] estimated a 5% to 25% 
measles mortality rate in developing areas; for comparison, a 1% 
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rate was noted in the United States during the measles epidemic 
in 1989–1990. In addition, measles infection greatly increases the 
risk of corneal ulceration and subsequent blindness among African 
children, particularly in those who are undernourished [1, 9].
Even in healthy children, measles virus infection is asso-
ciated with transient but severe immunosuppression [10, 11]. 
This infection-associated lymphopenia is short lived (approxi-
mately 1 week in duration), and only 1% to 5% of total periph-
eral lymphocytes are infected [10, 12, 13]. However, it has 
long been known that measles virus can grow in the spleen, 
lymph nodes, and tonsils [14], and studies finding  high per-
centages of measles virus–infected cells in lymphoid tissue 
[12] led de Vries et al [11] to reconsider lymphocyte depletion 
as a possible mechanism for virus-induced immunosuppres-
sion. They suggest that the marked increase of measles virus–
specific and bystander lymphocytes in response to infection 
resolves measles’ acute global lymphopenia yet masks subsets 
of immune-mediated lymphocyte depletion. In addition, in a 
large population study in England, Wales, the United States, and 
Denmark, in which mortality rates in the pre–measles vaccine 
era were compared with those in the vaccine era, the authors 
noted that the increased number of deaths from nonmeasles 
infectious diseases, hypothesized to be a consequence of pro-
longed immunosuppression that resulted from a depletion of 
memory lymphocytes, after high population levels of measles 
was not transient but, rather, lasted 2 to 3 years [15].
In a resource-poor area such as the DRC, limited health care 
services, poor nutrition, and high levels of infectious disease 
make host immune function of crucial public health impor-
tance. Therefore, identifying risk factors (such as previous 
measles infection) for adverse disease outcomes (such as fever, 
cough, or diarrhea) that result from postmeasles immunosup-
pression can result in valuable recommendations for DRC pub-
lic health policy and practice.
METHODS
Data Source and Study Population
The 2013–2014 DHS was conducted between November 2013 
and February 2014 and is a nationally representative survey 
based on a stratified 2-stage cluster design; the first stage con-
sisted of enumeration-area formation, and the second stage 
involved sampling households from each enumeration area 
[16–18]. In the first stage, a stratified sample of geographic 
locations, or clusters (n = 540), was selected with proportional 
probability according to size. Complete listings of households 
within each cluster were created and selected with equal prob-
ability (n  =  9000). For this study, 18 827 women aged 15 to 
49 years and 8656 men aged 15 to 59 years in 50% of the selected 
households were interviewed.
The DHS survey collected biomarker data on children if 
they were 6 to 59 months of age and in a household in which 
a male interview was conducted. Collected data included 
weight, anemia status, health outcomes, vaccination history, 
and vaccine-preventable disease serology. The University 
of California, Los Angeles (UCLA)–DRC laboratory at the 
National Laboratory for Biomedical Research in Kinshasa pro-
cessed dried blood spots (DBSs) collected from participants 
after parental consent and assessed them for immunity to vac-
cine-preventable diseases. Survey data were recorded on paper 
questionnaires and transferred to an electronic format using the 
Census and Survey Processing System (US Census Bureau, ICF 
Macro). Data were entered twice, and the resulting 2 data sets 
compared and verified.
Laboratory Analysis
DBS samples were extracted using a modified extraction pro-
tocol [19] and processed at the UCLA-DRC laboratory at the 
National Laboratory for Biomedical Research in Kinshasa. 
The DBS extraction and assay protocol and multiplex technol-
ogy have been described elsewhere [20]. The Dynex Multiplier 
chemiluminescent automated immunoassay platform with 
a research-use-only SmartPLEX assay for measles, mumps, 
rubella, varicella-zoster virus, and tetanus (Dynex Technologies, 
Chantilly, Virginia) was used to test samples for immunoglobulin 
G antibody response. An assay score (AS) was calculated for each 
assay as the ratio to a five-donor, pooled positive control included 
in each run. The limit of quantitation (LOQ) was calculated as an 
AS of 0.03, and this value (as a supplement to maternal report of 
measles) was used to indicate previous infection among children 
for whom a history of measles was reported. We used the LOQ 
in conjunction with maternal report to avoid missing cases of 
infants who might have had measles but failed to mount a robust 
immune response because of maternal antibody interference. 
As an internal validation, we compared measles antibody titers 
of children with a maternal measles report and those in children 
with no report, and we also conducted this analysis while limiting 
reports to those from mothers with a higher level of education to 
examine potential differences in reporting according to maternal 
education.
Study Design
We assessed the association of past measles disease with an 
increased prevalence of infectious disease markers among 2350 
children aged 9 to 59  months. Mothers selected for the DHS 
household interview reported whether their child had ever 
had measles and his or her approximate age (in months) at 
the time of illness. Of these children, those whose AS was less 
than the minimum antibody level of 0.03 were considered to 
be uninfected. This minimum antibody level was used to indi-
cate measles infection among those children for whom measles 
had already been reported, whereas antibody found among 
those for whom no disease was reported was considered vac-
cine induced. A child was considered vaccinated if, during the 
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interview, his or her mother presented the interviewer with a 
vaccination card (provided by a healthcare worker) that con-
tained the date that the child was vaccinated against measles 
[17]. Unvaccinated children were those reported as such in 
the DHS survey. Because of the cross-sectional nature of this 
study, we assessed the prevalence of maternally reported acute 
infectious disease markers (fever, cough, and diarrhea) during 
the 2-week reporting period before interview, as defined in the 
DHS survey. The final sample size was determined by variables 
available for each child.
Statistical Analysis
DHS surveys oversample or undersample different geographic 
areas, and the inclusion of individual-, stratum-, and clus-
ter-level weights is required for unbiased estimates and confi-
dence intervals (CIs) [18]. We used methods in SAS 9.4 (SAS 
Institute, Cary, North Carolina) that accounted for complex 
survey design [21], and to estimate variance correctly, all final 
analyses were single level.
In addition to a descriptive analysis according to measles 
status, we performed a second descriptive analysis according 
to the distribution of fever, cough, diarrhea, and fever/cough/
diarrhea (all 3 reported within the previous 2 weeks) outcomes 
to assess the imbalance of fever, cough, and diarrhea outcomes 
across demographic and socioeconomic variables. A  logistic 
regression model that accounted for survey design was used to 
examine the association between measles and episodes of fever, 
cough, or diarrhea. The model was run again to examine the 
association of measles with the occurrence of all 3 outcomes 
within the same 2-week period and then to examine the associ-
ation of outcomes with time (months) since measles. To account 
for potential miscategorization of time since measles infection, 
we categorized this analysis in 2 ways, by dividing at <12, <24, 
and 24 to 58  months (model 1)  and by dividing by approxi-
mately 9-month intervals up until 36 months and limiting the 
recall period to 3  years or less (model 2). To examine trends 
beyond the expected window for short-term immunosuppres-
sion caused by measles, children for whom measles infection 
was reported to have occurred less than 2  months before the 
interview were removed from the time-since-measles analysis. 
Because of the small cell sizes in this analysis, we also show the 
frequency data for all outcomes of interest within each month 
category.
Sensitivity Analysis
To examine potential effects of misclassification on odds 
ratio estimates, we included a sensitivity analysis in which we 
selected a simple random sample of measles cases to be consid-
ered misclassified and included these selected cases in the non-
measles group. In their study, Doshi et al [22] found that 48.6% 
of measles-like illness reports made using the DRC’s case-based 
surveillance system in 2010–2012 were laboratory confirmed to 
be positive. We therefore ran 4 models, first considering only 
29% of cases to be true positive and the remaining 71% to be 
false positive (and thus categorized as nonmeasles), and then 
we did the same for 39%, 49%, and 59% of the 193 measles cases 
in the full sample.
Covariate Selection
Covariate selection was based on a priori confounders (age, 
sex) and other potential confounders identified in the literature. 
Because areas with a high level of malnutrition tend to manifest 
greater severity in measles cases, we controlled for chronic mal-
nutrition by categorizing children as stunted or normally or over-
nourished, as calculated in the DHS and according to National 
Center for Health Statistics/Centers for Disease Control and 
Prevention/World Health Organization international reference 
standards [17]. Malaria status was included because it is a com-
mon cause of febrile illness [23] in this region, and vaccination, 
breastfeeding, maternal education (7 or more years), and low par-
ity were included because they have been found to be protective 
against child death [24–26]. Hobcraft et al [26] also found that 3 
or more births in a 2- to 6-year period potentially increases the 
mortality rate in children younger than 3 years, and we applied 
this criterion to define high versus low parity. To control for 
poverty, we created a binary variable from the DHS categorical 
wealth index variable (in quintiles) by categorizing the 2 lowest 
categories (“poorest” and “poorer”) as “poor” and the 3 high-
est categories (“middle,” “wealthy,” and “wealthiest”) as “middle 
income/wealthy.” We previously found that measles vaccination 
and wealth index have an interactive effect on markers of infec-
tious disease outcomes and thus included this interaction in our 
analysis; likewise, measles vaccination and DRC province have 
an interactive effect that we incorporated into our final model 
for fever, cough, and diarrhea outcomes. In addition, because the 
DHS wealth index variable depends on items more frequently 
found in urban than in rural residences, we included an interac-
tion variable (wealth index × residence) in the final model [27].
Although measles is known to have seasonal variation in 
nonindustrialized nations [28], the inclusion of seasonality 
was found to be minimally informative in this analysis and was 
not included in the final model because the data were collected 
within a short 4-month period and weather patterns across the 
DRC differ.
Although previous work on long-term immune effects 
of measles examined death as an outcome [15], data on all-
cause deaths between measles and nonmeasles cases were not 
available. Because the DHS primarily provides information 
on living children, we examined clinical markers of infection 
as our outcome of interest, which, to our knowledge, has not 
yet been examined in this context. Analyses were completed 
using SAS 9.4.
Ethical approval was obtained by the UCLA Fielding School 
of Public Health, the Kinshasa School of Public Health, and the 
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Centers for Disease Control and Prevention. Because the chil-
dren were younger than the standard age of assent, the parent 
or guardian of each participating child provided consent on that 
child’s behalf.
RESULTS
Internal Validation of Measles Categorization
Among the children with a maternal report of measles, 193 
(77%) of 252 had a measles antibody level of at least 0.03 AS. As 
an internal validation, we examined the correlation of measles 
antibody titer with maternal report of measles infection. Median 
measles antibody titer levels were higher among children with 
a maternal report of measles infection (median AS value, 0.507 
[95% CI, 0.223–0.791]) than among those with no report 
(median AS value, 0.176 [95% CI, 0.152–0.199]) (Supplementary 
Table 1). To explore the potential effect of maternal education on 
measles reporting, we conducted this analysis limited to mothers 
with 7 or more years of education and again found that children 
with maternal report of measles infection had higher measles 
antibody titer levels (median AS value, 0.742 [95% CI, 0.009–
1.476]) than those with no report of measles infection (median 
AS value, 0.203 [95% CI, 0.160–0.242]), although the CI for the 
group with report of measles infection among more highly edu-
cated mothers (n = 39) is notably wider than that from the group 
that included all observations (n = 705).
Descriptive Analyses
We observed differences (Table 1) between history of measles di-
sease and vaccination status (P = .0036, Wald χ2), age (P < .0001, 
Wald χ2), breastfeeding status (P < .0001, Wald χ2), years of ma-
ternal education (P = .0086, Wald χ2), DRC province (P = .0006, 
Wald χ2), and fever outcome (P = .0485, Wald χ2). Examination 
of demographic and socioeconomic variables according to 
fever, cough, and diarrhea outcomes (Supplementary Table 2) 
revealed differences according to vaccination status for diarrhea 
outcome (P  =  .0131, Wald χ2), age (P  =  .0025, .0032, <.0001, 
and .0003 for fever, cough, diarrhea, and fever/cough/diarrhea, 
respectively, Wald χ2), and breastfeeding status for all outcomes 
except cough. Other differences included cough outcome 
according to wealth index and residence (P =  .0114, Wald χ2) 
and fever outcome according to malaria result and measles his-
tory (P = .0018, Wald χ2). Controlled for covariates, logistic re-
gression analyses (Table 2) revealed that children with a history 
of measles disease had greater odds of experiencing a fever epi-
sode within the 2 weeks before interview (odds ratio [OR], 1.80 
[95% CI, 1.25–2.60]). Measles vaccination was associated with 
decreased odds of fever, diarrhea, and fever/cough/diarrhea, 
and a positive malaria test result was associated with increased 
odds of fever. The sensitivity analysis that examined changes 
in outcome according to potential percentage of measles cases 
misclassified (Supplementary Table  3) revealed a continued 
association with previous measles infection and increased odds 
of fever if as many as half of the measles reports had been mis-
classified. The trend in association continued for higher levels of 
misclassification but was not statistically significant.
Time-Since-Measles Analysis
Of 177 children for whom the date of measles infection was 
given and who met inclusion criteria, the median time since 
disease was 14.8 months (standard error, 1.08 months; range, 
0–57  months). We performed logistic regression analyses to 
examine associations with acute fever, cough, or diarrhea epi-
sodes and a categorical “time (months) since measles” variable 
(Table 3). Trends of increased odds for fever outcome among 
children with measles disease were found in all 3 time catego-
ries (reference category, no history of measles) but were statis-
tically significant in only the 13–24 month category (OR, 2.08 
[95% CI, 0.96–4.51]) for model 1 and for the 10- to 18-month 
(OR, 1.93 [95% CI, 1.03–3.62]) and 19- to 27-month (OR, 3.01 
[95% CI, 1.18–7.67]) age categories for model 2. Although not 
all estimates were statistically significant, the fever outcome 
showed consistently elevated trends. In Supplementary Table 4, 
model 1 data show that approximately 50% of the children with 
measles disease history in the previous 2 years also had a report 
of fever within the previous 2 weeks, compared with 35% of the 
children with no measles disease history and a report of recent 
fever. Model 2, which categorized time in 8- to 9-month inter-
vals, shows a similar trend for children with history of measles 
disease in the previous 3 years.
DISCUSSION
The results of our analysis suggest that previous measles in-
fection, as reported via maternal recall and meeting serologic 
criteria, was associated with increased odds of fever outcomes 
among children aged 9 to 59 months, which supports the hy-
pothesis of immune-amnesia leading to a prolonged period of 
increased risk for death as a result of non-measles infectious 
diseases. The association of infectious disease markers with 
time in months since measles infection also suggests some 
support for this hypothesis. Although most estimates were 
not statistically significant, this lack of statistical significance 
might have been a result of the small number of children with 
a history of measles in each category, and we found a trend of 
prolonged association with fever beyond the weeks after mea-
sles infection. The lack of association between measles and 
cough might have been a result of environmental or indoor 
pollution having a greater effect on respiratory illness than 
previous history of measles disease since environmental pollu-
tion is known to cause respiratory symptoms in children [29], 
and indoor air-pollution exposure is a public health concern 
in many areas of sub-Saharan Africa [30].We also found no as-
sociation between past measles infection and recent diarrhea. 
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Table 1. Descriptive Data of Children Aged 9 to 59 Months With and Those Without a History of Measles Infection
All Children Children With Measles Infection History
Variable n % of Total n % of Category P  a
Vaccinated against measles .0036
 No 1608 68 157 10
 Yes 742 32 36 5
Age (mo) <.0001
 9–11 264 11 11 4
 12–23 725 31 36 5
 24–35 547 23 42 8
 36–47 434 18 57 13
 48–59 381 16 47 12
Breastfeeding <.0001
 Never 52 2 4 8
 Past 1395 59 151 11
 Current 964 41 38 4
Maternal education .0086
 <7 years 1605 68 154 10
 ≥7 years 745 32 39 5
DRC province .0006
 Kinshasa 149 6 8 5
 Bandundu 318 14 20 6
 Bas-Congo 83 4 0 0
 Equateur 366 16 42 11
 Kasai-Occidental 234 10 6 3
 Kasai-Oriental 287 12 35 12
 Katanga 282 12 23 8
 Maniema 87 4 5 6
 Nord-Kivu 245 10 19 8
 Orientale 165 7 31 19
 Sud-Kivu 133 6 4 3
Sex .5963
 Male 1134 48 97 9
 Female 1216 52 96 8
Wealth indexb .3213
 Poor 1149 49 104 9
 Middle income/wealthy 1201 51 89 7
Residence .2117
 Urban 704 30 48 7
 Rural 1646 70 145 9
Chronically malnourishedc .2924
 Yes 1122 48 99 9
 No 1228 52 94 8
Children <5 years old in household .5027
 <3 children 1602 68 126 8
 ≥3 children 747 32 67 9
Malaria (blood smear) result .4685
 Negative 1825 78 145 8
 Positive 525 22 48 9
Fever .0485
 Yes 830 35 84 10
 No 1519 65 109 7
Cough .5885
 Yes 832 35 73 9
 No 1518 65 120 8
Diarrhea .7523
 Yes 534 23 42 8
 No 1816 77 151 8
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A possible reason is that measles virus might not target all in-
testinal lymphoid tissue. Although findings of  de Swart and 
coworkers [12] indicated that lymphoid tissue in the small and 
large intestinal submucosa of the macaque is  a target for mea-
sles virus, no evidence of infected cells in the epithelial layer 
was found. If prolonged measles-induced immunosuppression 
were to affect primarily cells of the submucosa and leave lym-
phoid cells in the intestinal epithelium unaffected,  this may 
suggest that these intact cells could provide some compensa-
tion for immunomodulation caused by submucosal lymphoid 
cell depletion.
We found that measles vaccination had a protective associa-
tion against fever, diarrhea, and fever/cough/diarrhea. Measles 
vaccination may exert beneficial nonspecific effects that are 
thought to affect resistance to infectious diseases other than 
the targeted disease [31], and both observational and random-
ized trials from low-income countries have found an associa-
tion between measles vaccination and reduced overall death 
and morbidity that cannot be explained by the prevention of 
measles alone [32–39]. A  potential reason for why a protec-
tive association between measles vaccine between all 3 symp-
toms, but not cough alone, was found is that, as described 
above, other risk factors may mask a potential underlying as-
sociation between measles vaccination and cough that becomes 
statistically significant when a child experiences all 3 outcomes. 
Alternatively, children who experience all 3 symptoms might 
be more likely to have a cough of infectious origin than those 
children who had only cough. Malaria symptoms and treatment 
are commonly associated with fever [23], which agrees with the 
associations found in our analyses.
Additional research is warranted to determine how much of 
the association of protection against fever, diarrhea, and fever/
cough/diarrhea is a result of measles vaccination itself apart 
from the prevention of measles disease. The nearly null asso-
ciation with cough could be because of the high prevalence of 
asthma and other chronic respiratory disorders that are signifi-
cant causes of morbidity and death in sub-Saharan Africa [40], 
but that we were unable to assess it in this study.
To our knowledge, ours is the first study to have examined 
the association of previous measles infection with a prolonged 
increase in the prevalence of acute infectious disease clin-
ical  markers. The strengths of this study include its large, na-
tionally representative sample, increased confidence in maternal 
measles report because of serologic test results that revealed dif-
ferences in median serum antibody levels between children with 
and those without a report of measles infection, and collection 
of the date of measles infection to assess its association with epi-
sodes of fever, cough, or diarrhea over time. There were several 
All Children Children With Measles Infection History
Variable n % of Total n % of Category P  a
Fever/cough/diarrhea .3323
 Yes 200 9 21 11
 No 2150 91 172 8
Total 2350 — 193 8
aWald χ2 test for independence of measles status and row variables. Values in bold type indicate statistical significance.
bWealth index is the Demographic and Health Survey composite measure of a household’s cumulative living standard. On the basis of household ownership of previously selected assets and using principal components analysis, 
households were placed within 1 of 5 quintiles. For the dichotomized variable, we combined the 2 lowest categories into the “poor” category and the 3 wealthiest into the “middle income/wealthy” category.
cCalculated according to the National Center for Health Statistics/Centers for Disease Control and Prevention/World Health Organization international reference standard for height and age, dichotomized as −2.0 to less than or 
equal to −3.0 standard deviations (SDs) below the mean for chronically malnourished children and normal to ≥3.0 SDs above the mean for normally and overnourished children.
Table 1. Continued
Table 2. Association of Measles Disease History With Acute Infectious Disease Episodes of Fever, Cough, Diarrhea, and Fever/Cough/Diarrhea in the 2 
Weeks Before Interview Among Children Aged 9 to 59 Months
Variable
OR (95% CI) fora:
Feverb Cough Diarrhea Fever/Cough/Diarrheac
Measlesd 1.80 (1.25–2.60) 1.24 (0.82–1.86) 1.24 (0.80–1.93) 1.74 (0.96–3.15)
Selected covariates
 Received measles vaccination 0.53 (0.35–0.82) 0.76 (0.51–1.13) 0.25 (0.17–0.37) 0.51 (0.30–0.88)
 Malaria positive 1.54 (1.16–2.03) 0.89 (0.66–1.19) 1.03 (0.78–1.35) 0.94 (0.61–1.45)
Abbreviations: CI, confidence interval; OR, odds ratio.
aValues in bold type indicate statistical significance.
bControlled for the following additional covariates: measles vaccination (vx), wealth index (WI), vx × WI interaction, breastfeeding, maternal education, parity, age, sex, malaria-positive status, rural versus urban residence, 
residence × WI interaction, (old) DRC province, vx × DRC province interaction, and chronic malnutrition (according to National Center for Health Statistics/Centers for Disease Control and Prevention/World Health Organization 
international reference standards for height and age standard deviations).
cBecause of the reduced number of outcomes for fever/cough/diarrhea, the vx × DRC province interaction variable was removed from the model.
dWe used 2350 observations in the regression model for all outcomes of fever, cough, diarrhea, and fever/cough/diarrhea.
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limitations to this study. (1) Measles reports were not labora-
tory confirmed. Although measles diagnosis based on clinical 
signs has been shown to be unreliable in more highly vaccinated 
countries, it is still thought to be a sensitive method for detecting 
measles infection [41, 43], and the high prevalence of measles in 
the DRC [42] might increase the positive predictive value (PPV) 
of a clinical measles diagnosis compared to that in countries 
with lower measles prevalence; previous work found the PPV of 
clinical measles diagnosis to be improved in higher-prevalence 
locations [43]. (2) Although clinical signs of measles, particu-
larly Koplik spots [43], can provide a higher PPV in higher-prev-
alence areas, measles reports were obtained from mothers rather 
than trained healthcare workers and so might have been less re-
liable. However, previous work has indicated that maternal recall 
of symptoms associated with childhood deaths, including death 
caused by measles, in sub-Saharan Africa were reported with a 
high degree of accuracy, and recollections of signs and symptoms 
within 1 month versus within 6 months of a child’s death were 
found to be similar [44]. Moreover, despite the lack of health-
care practitioner reports of disease, we substantiated maternal 
reports of measles infection with serology and therefore lessened 
the possibility of exposure misclassification. If misclassification 
of measles did occur, it would likely be nondifferential, because 
inaccurate maternal memory or assessment of measles disease 
would likely be relatively equal across demographic groups, 
which would bias estimates toward the null. An  exception to 
this tendency toward non-differential misclassification  might 
be found among  reports from more highly educated mothers. 
This group did demonstrate a statistically significant difference 
in reported measles cases compared to those from less educated 
mothers, but this difference could be a result of mothers in the 
highly educated group (in urban settings) being more likely to 
have vaccinated their children against measles [45]. Such dif-
ferential misclassification could bias the estimate toward or 
away from the null [46], but we attempted to account for this 
limitation with a sensitivity analysis, which revealed a continued 
association with past measles disease and fever even if nearly half 
of the measles cases had been misclassified. (3) Elevated levels of 
malnutrition in regions such as the DRC can drive measles-re-
lated mortality rates as high as 6% [47]. Survivor bias might have 
occurred in our study, because the most severely affected chil-
dren might have died and thus would not have been included 
in the analyses; however, survivor bias would likely influence 
estimates toward the null. (4) The cross-sectional nature of the 
survey might have missed acute infectious disease episodes in 
children who truly experienced an overall increased incidence 
caused by previous measles infection but who did not experience 
disease in the 2-week reporting window for the DHS survey.
In conclusion, our findings provide support for the hypothe-
sis of measles-induced prolonged immunosuppression suggested 
by others and underscore the need for continued evaluation and 
improvement of the measles vaccination program in the DRC. 
Elevating vaccination coverage in the least-reached areas is an 
important component of strengthening the national vaccina-
tion program to control and eliminate measles [45]. In addi-
tion, more studies in wealthy countries could further clarify 
the immune-amnesia hypothesis. An increase in the number of 
infectious disease episodes over the long term in children who 
have a history of measles infection puts added strain on both the 
local health system and on the wellness of other children with 
whom the infected child comes in contact. The profound effect of 
measles on the lives and health of children in sub-Saharan Africa 
warrants concerted efforts toward the mitigation and elimination 
of this disease, and better defining the risks that measles poses 
to child health can drive and refine vaccination program policy.
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Table 3. Association of Time in Months Since Measles Disease With Acute Infectious Disease Episode of Fever, Cough, or Diarrhea in the Previous Two 
Weeks Among Children 9–59 Months of Age.
Time Since Measles (months)b
Fever Cough Diarrhea
 OR and 95% CIa OR and 95% CI OR and 95% CI
Model 1 (2–57 months)
 2–12 (n = 62) 2.08 (0.96–4.51) 1.53 (0.70–3.33) 1.02 (0.50–2.11)
 13–24 (n = 54) 2.14 (1.12–4.08) 0.94 (0.41–2.17) 1.44 (0.75–2.78)
 25–57 (n = 60) 1.54 (0.82–2.87) 1.37 (0.76–2.46) 1.58 (0.74–3.37)
Model 2 (2–36 months)
 2–9 (n = 54) 1.79 (0.80–3.99) 1.71 (0.74–3.97) 1.14 (0.50–2.63)
 10–18 (n = 46) 1.93 (1.03–3.62) 1.02 (0.50–2.10) 1.36 (0.68–2.71)
 19–27 (n = 24) 3.01 (1.18–7.67) 1.54 (0.63–3.75) 1.08 (0.35–3.32)
 28–36 (n = 30) 1.94 (0.80–4.71) 1.59 (0.68–3.73) 2.58 (0.93–7.13)
aControlling for the following additional covariates: measles vaccination (vx), wealth index (WI), vx*WI interaction, breastfeeding, maternal education, parity, age, sex, malaria positive status, rural versus urban residence, resi-
dence*WI interaction, (old) province, vx*province interaction, and chronic malnutrition (according to NCHS/CDC/WHO international references standard for height/age SD).
bReference = No history of measles (n=2,157).
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